Riewpaiboon Arthorn
Division of Social and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand.
J Med Assoc Thai. 2008 Jun;91 Suppl 2:S28-37.
Costing plays an important role in health economics, particularly economic evaluation. However, there are some controversial issues: concepts, methods and reference values. Hence, it is pivotal to standardize can be con costing methods and use these as national guidelines to produce comparable studies. This report is divided perspectives. into 3 parts: theoretical issues, international guidelines comparison, and recommendations for the Thai technology assessment guidelines. Each section is composed of three general costing steps: identification, appropriate, measuring and valuation. It is recommended to measure economic or opportunity cost mainly in societal perspective. Cost category is composed of direct medical, direct non-medical and indirect costs. The level of reliability of each kind of costing source data is provided. Valuation of resource use based on national government, standard cost menu is recommended for national policy making. The recommendations on cost measurement are appropriate for the Thai context and in the current situation.
成本核算在卫生经济学中,尤其是在经济评估中发挥着重要作用。然而,存在一些有争议的问题:概念、方法和参考值。因此,规范成本核算方法并将其用作国家指南以开展可比较的研究至关重要。本报告分为三个部分:理论问题、国际指南比较以及对泰国技术评估指南的建议。每个部分都由三个一般成本核算步骤组成:识别、计量和估值。建议主要从社会角度计量经济成本或机会成本。成本类别由直接医疗成本、直接非医疗成本和间接成本组成。提供了各类成本核算源数据的可靠程度。建议基于国家政府标准成本清单对资源使用进行估值,以用于国家政策制定。关于成本计量的建议适用于泰国的情况和当前形势。